FOS and bone neoplasm: Mechanistically, we found that EGFR is essential for proliferation, survival, and MAPK‐dependent activation of pCREB/c‐Fos in bone tumors of H2‐c‐fosLTR mice and in orthotopically injected human 143b OS cells, which are positive for both EGFR and Fos.